Shapiro David
SEC insider (Form 3/4/5 filer). CIK 0001559570. Director at Design Therapeutics, Inc. (DSGN) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CARLSBAD, CA.
Companies Shapiro David has filed insider reports for
- Design Therapeutics, Inc. (DSGN): Director
- Galecto, Inc. (GLTO): Director
Shapiro David
CIK: 0001559570
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 9, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30K shares- - Mar 31, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
60K shares- - Mar 31, 2026DSGN
Design Therapeutics, Inc.
AwardDirectStock option (right to buy)
7.5K shares- - Jun 18, 2025GLTO
Galecto, Inc.
AwardDirectStock Option (right to buy)
720 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  DSGN Design Therapeutics, Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Mar 31, 2026 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 60,000 | - | - | Direct |
| Mar 31, 2026 | DSGN Design Therapeutics, Inc. | Award Stock option (right to buy) | 7,500 | - | - | Direct |
| Jun 18, 2025 |  GLTO Galecto, Inc. | Award Stock Option (right to buy) | 720 | - | - | Direct |
1-4 of 4 transactions